Levetiracetam Kent

Levetiracetam, the active ingredient in Levetiracetam Kent, is an antiepileptic presented as an intravenous formulation for intravenous use. It helps reduce the frequency of partial, generalized tonic‑clonic and myoclonic seizures in individuals diagnosed with epilepsy, and is indicated for both adult and pediatric patients when oral administration is not feasible.

GNH USA supplies Levetiracetam Kent as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic drug used to manage seizure disorders. - Partial seizures: reduces frequency and severity of focal seizures. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes. - Myoclonic seizures: decreases occurrence of sudden muscle jerks. - Epilepsy (overall): contributes to overall seizure control in patients with epilepsy.

Levetiracetam may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Fatigue: feeling unusually tired or weak. - Headache: mild to moderate cranial pain. - Nausea: upset stomach or urge to vomit.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Mood changes: depression, suicidal thoughts, or agitation. - Blood disorders: thrombocytopenia or leukopenia.

Before initiating therapy, consider the following safety measures. - Renal function: adjust use in patients with impaired kidney function. - Concomitant CNS depressants: monitor for enhanced sedation. - Pregnancy: limited data; weigh benefits against potential risks. - Psychiatric history: observe for mood alterations or suicidal ideation. - Storage: Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Levetiracetam can interact with several medicines; awareness helps maintain efficacy and safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenobarbital: may decrease efficacy of levetiracetam.

Moderate Interactions (Monitor Closely): - Alcohol: can increase central nervous system depression. - Opioids: may enhance sedation and respiratory depression. - Other antiepileptics (e.g., valproate): monitor seizure control.